A detailed history of Prime Capital Investment Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 7,727 shares of XBI stock, worth $753,459. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,727
Previous 6,464 19.54%
Holding current value
$753,459
Previous $577,000 27.04%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$87.05 - $102.89 $109,944 - $129,950
1,263 Added 19.54%
7,727 $733,000
Q4 2023

Jan 24, 2024

BUY
$64.12 - $90.86 $142,859 - $202,436
2,228 Added 52.6%
6,464 $577,000
Q3 2023

Nov 09, 2023

BUY
$71.88 - $85.76 $16,244 - $19,381
226 Added 5.64%
4,236 $309,000
Q2 2023

Aug 08, 2023

BUY
$75.38 - $90.23 $302,273 - $361,822
4,010 New
4,010 $333,000
Q4 2022

Feb 08, 2023

BUY
$77.2 - $85.66 $400,976 - $444,918
5,194 Added 192.37%
7,894 $655,000
Q3 2022

Nov 08, 2022

BUY
N/A
2,700 New
2,700 $214,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.